Radboud-Glasgow Collaboration Fund opens to applications
Issued: Thu, 07 Feb 2019 18:07:00 GMT
The University of Glasgow signed a strategic partnership agreement with Radboud University in the Netherlands last June.
That Memorandum of Understanding commits the two research-intensive universities to invest jointly in extending their world-class research and enhancing their student experience. It also established the Radboud-Glasgow Collaboration Fund to which applications opened on 8 February and will close on 29 March. Successful applicants will be notified on 18 April.
The fund has been established to:
- Facilitate and support joint initiatives that will strengthen the two universities’ strategic priorities;
- Encourage innovative learning and teaching practices and initiatives;
- Facilitate multi-disciplinary and cutting-edge research;
- Encourage international staff mobility and provide opportunities for development.
The fund is seeking proposals for three different types of project:
- Research (in any discipline, for one-year projects)
- Learning and Teaching (teaching initiatives such as dual degrees, jointly taught modules etc.)
- Short-term staff mobility (professional development; exchange of knowledge and experience (e.g. work shadowing); to deliver guest lectures; or to develop a new collaboration initiative; to prepare an external grant funding proposal
The maximum budget for each Research and Learning & Teaching project is £20,000 and there is a maximum budget of £2,000 for each short-term mobility proposal.
Each successful project will be awarded funding for one year, with the possibility of a second year of funding subject to a new application being submitted. Applications are invited from academic and professional from all disciplines at Radboud and Glasgow and their affiliated Research Centres and Institutes. Applicants must have an active contract of employment with one of the partner institutions (appointed at least 0.5 FTE). If on a fixed term contract, the end date must be beyond the funding period. Further information available.